Open AccessAdjuvant EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: still an investigational approach
Author(s) -
Jacek Jassem
Publication year - 2019
Publication title -
translational lung cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 41
eISSN - 2226-4477
pISSN - 2218-6751
DOI - 10.21037/tlcr.2019.09.02
Subject(s) - medicine , adjuvant , lung cancer , tyrosine kinase , cancer research , mutant , non small cell lung cancer (nsclc) , cancer , protein tyrosine kinases , oncology , biology , receptor , biochemistry , gene , a549 cell